Company intelligence / Profile preview

B-Organic

Montreal, Quebec, Canadaborganics.cl ↗

Ownership: Private
Development stage: Commercial

Overview

B-Organic develops patented excipient technologies to enhance the bioavailability of poorly soluble drugs and bioactive compounds. The company also works on natural mineral-based immunostimulants for disease prevention in aquaculture and agriculture. No clinical trial results or marketed products are reported as of now[1][7].

Therapeutic areas: OtherMetabolic DisordersInfectious Diseases
Modalities: Small moleculeBiologicExcipient technology
Industry: Chemicals & Materials

Partnerships

Not publicly disclosed as of June 2025.

Beyond the preview

Go deeper on B-Organic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on B-Organic.

Explore the full profile